- Home
- ISD vs SOPH Comparison
ISD vs SOPH Comparison
Compare ISD & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ISD | SOPH |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.2M | 367.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ISD | SOPH |
|---|---|---|
| Price | $13.23 | $4.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 106.8K | 94.0K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 9.69% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.38 | $2.58 |
| 52 Week High | $14.79 | $5.70 |
Technical Indicators
Market Signals| Indicator | ISD | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.61 | 51.88 |
| Support Level | $12.53 | $4.54 |
| Resistance Level | $14.64 | $5.31 |
| Average True Range (ATR) | 0.29 | 0.31 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 72.63 | 40.62 |
Price Performance
Historical ComparisonAbout ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.